We are delighted to welcome you to the latest issue of EMJ Allergy & Immunology. Sharing key updates in the field in the form of reviews and research articles, our latest issue features insights into paediatric allergen–specific immunotherapy studies, mast–cell mediated diseases, and the role of Janus kinase inhibitors in rheumatoid arthritis, as well as spotlighting interesting dermatitis case reports. Also included, is a comprehensive review of the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2022, with late breaking abstract reviews featuring novel research.
EMJ Allergy & Immunology 7.1 2022
August 2022
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given